Amalgamated Financial’s Treace Medical Concepts TMCI Stock Holding History

Amalgamated Financial’s Portfolio TMCI Stock Details TMCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$93K	Buy	+4,898	New	+$95.2K	﹤0.01%	2176

Other funds holding TMCI

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Amalgamated Financial's TMCI Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Treace Medical Concepts (TMCI) in Q1 2022: 4,898 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #2176 among its holdings.

75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

Amalgamated Financial held 4,898 shares of Treace Medical Concepts worth $93K as of Q1 2022.
Treace Medical Concepts was a new Amalgamated Financial position in Q1 2022.
Treace Medical Concepts made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2176 holding.
75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.